Serum IGF-II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer

Status unconfirmed

Conditions studied: Cervical Cancer, Cervical Intraepithelial Neoplasia II, Cervical Intraepithelial Neoplasia III

In brief

The purpose of this study is to determine whether Insulin-like Growth Factor II is elevated sufficiently to detect Cervical Intraepithelial Neoplasia II (CIN II), Cervical Intraepithelial Neoplasia III (CIN III), and cervical cancer.

Key facts

Study ID

NCT01371695

Run by

Onconix, Inc

People needed

60

Starts

2011-05-01

Expected to finish

2013-09-01

Last updated by the study team

2011-06-13

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 18 - 75 years
• Female
• Normal medical history
• Medical history of a single type of cancer confirmed by biopsy or equivalent criteria
• Squamous cell carcinoma of organs other than cervix
• Adenocarcinoma
• Medical history of inflammatory disease
• May be pregnant
• Pap smear positive for Cervical Intraepithelial Neoplasia II or III
• Squamous cell cervical cancer confirmed by biopsy
• Informed consent
• Willingness to submit a blood sample by venipuncture
• Willingness to submit a second blood sample if necessary

You may not qualify if…

• Age < 18 or > 75 years
• Medical history of cancer other than cervical cancer, Non-islet-cell tumor hypoglycemia, Growth hormone deficiency, Acromegaly, Hepatoma, inflammatory disease in addition to confirmed CIN and cervical cancer

Where it is running

• Georgia Health Sciences — Augusta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.